T Cells Dysfunction in Multiple Myeloma
ImmunoTargets and Therapy · 2025-09 · Volume 14 · 997-1014
DOI: 10.2147/itt.s534784 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ImmunoTargets and Therapy, 2025-09. Verfasst von Linyu Cai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, People's Republ…. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Multiple myeloma (MM) is a kind of plasma cell hematologic malignancy. Notable advancements in patient survival have been achieved due to the clinical application of anti-CD38 monoclonal antibody, chimeric antigen receptor T cells (CAR-T) and bispecific T cell engagers (TCEs). However, the immunosuppressive microenvironment of the bone marrow hinders the effectiveness of these novel immunotherapies, consequently restricting their efficacy. Hence, it is imperative to clarify the exact mechanisms to devise strategies aimed at improving the efficacy of immunotherapy. In this review, we provide a systematic overview of recent research concerning the different T cell subtypes in the immune evasion mechanisms of MM. The review emphasizes the imbalance between the immune surveillance and the immune suppression, and highlight recent studies about unconventional T cells, the metabolic control of immune reactions, and novel therapeutic strategies aimed at addressing immune evasion mechanisms that promote the progression of MM.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, People's Republic of China.
- Key Laboratory of Biological Targeted Therapy (Huazhong University of Science and Technology), Ministry of Education, Wuhan, Hubei, 430022, People's Republic of China.
ORCID-Profile: Linyu Cai
Zitieren
APA
Cai, L., Zuo, L., Wang, G., Li, Q., Ma, C., Wu, J., Sun, C., & Hu, Y. (2025). T Cells Dysfunction in Multiple Myeloma. ImmunoTargets and Therapy, Volume 14, 997-1014. https://doi.org/10.2147/itt.s534784
Vancouver
Cai L, Zuo L, Wang G, Li Q, Ma C, Wu J, et al. T Cells Dysfunction in Multiple Myeloma. ImmunoTargets and Therapy. 2025;Volume 14:997-1014. doi:10.2147/itt.s534784
BibTeX
@article{Cai2025,
author = {Cai, Linyu and Zuo, Liping and Wang, Guangqi and Li, Qun and Ma, Chi and Wu, Jianghua and Sun, Chunyan and Hu, Yu},
title = {T Cells Dysfunction in Multiple Myeloma},
journal = {ImmunoTargets and Therapy},
year = {2025},
volume = {Volume 14},
pages = {997--1014},
doi = {10.2147/itt.s534784}
}
EUVIMED